基于生物信息学与分子对接技术对坛紫菜降血压肽的筛选及活性分析

采用木瓜蛋白酶和糜蛋白酶双酶联合水解坛紫菜蛋白（Porphyra haitanensis protein,PHP）制备降血压活性肽,测定了经超滤后各个分子质量PHP酶解液清除1,1-二苯基-2-三硝基苯肼（1,1-diphenyl-2-picrylhydrazyl,DPPH）自由基和2,2’-联氮双(3-乙基苯并噻唑啉-6-磺酸)（2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid),ABTS）阳离子自由基能力、铁离子还原抗氧化能力（ferric ion reducing antioxidant power,FRAP）以及血管紧张素转化酶（angiotensin converting enzyme,ACE）抑制活性。经质谱鉴定和活性肽数据库BIOPEP以及AHTPDB网站查找筛选活性肽,采用分子对接解释多肽抑制ACE机理,并对双酶酶解PHP动力学进行研究。结果表明：经超滤后的8?个分子质量的坛紫菜多肽组分中,＜0.5?kDa的组分具有最高DPPH自由基和ABTS阳离子自由基清除能力,＜1?kDa的组分具有最高FRAP值,而0.5～1?kDa组分IC50值（（2.21±0.28）mg/mL）最低。经查找筛选出14?条降血压肽,其中4?条肽的序列和对接能量分别为AVP（－5.87?kJ/mol）、GPL（－6.13?kJ/mol）、LDY（－7.65?kJ/mol）和LGYL（－7.78?kJ/mol）。酶解动力学模型预测PHP水解度与实验水解度相对误差在10%以下。本实验基于串联质谱与分子对接技术,通过生物信息筛选和体外活性检测从混合多肽中快速鉴定、筛选活性多肽,探究多肽抑制ACE的机理,并建立了描述蛋白可控酶解过程规律的动力学模型,为活性肽的制备提供了参考和借鉴。     

豆粕血管紧张素转化酶抑制肽的结构鉴定及作用机制解析

以大豆粕为原材料,利用超声辅助酶解技术、超滤-?KTA层析相结合的方法分离纯化获取豆粕酶解产物中血管紧张素转化酶（angiotensin-converting enzyme,ACE）抑制肽,对其分子质量分布进行研究,后通过质谱分析与分子对接技术鉴定并筛选出ACE抑制活性肽的氨基酸序列,经固相合成肽序列,检测其ACE抑制肽的活性并基于分子对接技术探索其抑制机制。结果表明：经超声辅助酶解提取获得的豆粕肽分子质量主要分布在6 000 Da以下;根据分子对接的最低预测自由能筛选出的GVRP（－8.44 kcal/mol）和IIVTP（－9.04 kcal/mol）可以抑制ACE活性,半抑制浓度（50% inhibitory concentration,IC50）分别为（84±0.06）、（77±0.08）μmol/L;分子对接结果表明：GVRP、IIVTP能够与ACE的活性口袋S1、S1′、S2形成氢键相互作用,共有的过近接触（3.5 ?范围内）ACE氨基酸残基为His513、Ala354和Glu384。本研究基于串联质谱与分子对接技术,建立从混合多肽中快速鉴定、筛选活性多肽的方法,探究活性多肽与ACE稳定结合并体现其ACE活性的抑制机制,为后续的深入研究提供一定参考。     

一种新型绵羊乳酪蛋白ACE抑制肽结构鉴定及分子结合机制分析

本研究旨在利用蛋白酶水解绵羊乳酪蛋白,制备新型血管紧张素转化酶（Angiotensin-I-Converting Enzyme,ACE）抑制肽并对其分子抑制机制进行分析,为功能性绵羊乳多肽乳制品开发提供技术支持。试验以绵羊乳酪蛋白为原料,以水解度、ACE抑制率和分子量分布为评价指标,从四种蛋白酶中筛选最适蛋白酶,选择<3 kDa的组分通过LTQ Orbitrap Velos质谱仪进行肽鉴定,筛选潜在的ACE抑制肽进行人工合成并测定其半抑制浓度（IC₅₀）,采用Linewaver-Burk作图确定酶抑制动力学,结合分子对接进一步解释肽段的抑制机制。结果表明:碱性蛋白酶为最佳水解蛋白酶;从κ-酪蛋白中筛选出一种新的ACE抑制肽KYIPIQY,半抑制浓度（IC₅₀）为5.73 μmol/L;Linewaver-Burk图表明该肽对ACE为混合型抑制模式;分子对接显示,KYIPIQY通过与ACE的S1和S2活性口袋形成氢键和疏水作用力发生紧密结合并且可以扭曲ACE的Zn2+四面体,抑制ACE催化活性的失活而发挥高效的ACE抑制活性。     

贻贝盐溶蛋白特性分析及其ACE抑制肽的酶法制备

以贻贝为原料提取盐溶性蛋白,首先研究盐溶性蛋白的分子质量分布、粒度分布和变性温度等性质,然后比较其3?种蛋白酶（胰蛋白酶、中性蛋白酶和胰酶）酶解产物的血管紧张素转化酶（angiotensin converting enzyme,ACE）抑制活性,筛选出ACE抑制活性较高的胰蛋白酶酶解物,其IC50值为215.96?μg/mL。利用质谱对胰蛋白酶酶解物中的多肽氨基酸序列进行鉴定,利用多肽序列与ACE的对接分数初步筛选出11?个分值大于180?分的多肽序列,通过氨基酸组成结合情况和两者间氢键等相互作用,进一步筛选活性肽并阐述抑制活性机理,最终推测出LYDIDVAK和WIAEEADK是活性较高的抑制肽。     

具ACE抑制活性的油茶饼粕酶解物的制备及分离表征

以油茶饼粕为原料,研究通过5种蛋白酶水解制备的茶粕酶解物ACE抑制率随酶解时间的变化规律,结果表明除蛋白酶C外,其余4种蛋白酶水解的茶粕酶解物ACE抑制率随酶解时间呈现先增加后减小的趋势。比较不同蛋白酶水解的茶粕酶解物ACE抑制活性得出经蛋白酶A水解后的茶粕酶解物具有较高的ACE抑制率(94.4%);为获得高纯度并具有高ACE抑制活性的酶解组分,文章采用CM-Sephadex C-25阳离子交换色谱和RP-HPLC纯化经蛋白酶A酶解的茶粕酶解物。由CM-Sephadex C-25阳离子交换色谱分离得到一个组分A,通过RP-HPLC进一步分离组分A得到6个组分。对ACE抑制率最高的组分A-2进行RP-HPLC二次纯化,得出该分离组分达到色谱纯,其半数抑制浓度(IC_(50))为98μg.m L~(-1)。     

酶解法制备绵羊乳酪蛋白ACE抑制肽的工艺优化及其抑制机制

为优化酶解法制备绵羊乳酪蛋白ACE抑制肽的工艺条件以及筛选和鉴定一种新的ACE抑制肽,选用5种蛋白酶水解酪蛋白,以水解度、分子质量分布和ACE抑制率为指标筛选最适蛋白酶,采用单因素和响应面试验优化工艺,采用三合一质谱仪(Orbitrap Fusion Lumos Tribrid MS)方法鉴定分子质量小于3 ku组分的氨基酸序列,筛选潜在ACE抑制肽,进行人工合成,测定其IC50值。采用Linewaver-Burk作图确定酶抑制动力学,结合分子对接解析肽段的抑制机制。结果表明:碱性蛋白酶水解酪蛋白的最佳条件为pH 6、底物含量8%、酶添加量4%、温度55 ℃、水解时间90 min,此时酪蛋白水解液ACE抑制率为99.1%。验证具有ACE抑制活性的肽段10条,筛选出一条新颖的降血压肽——LFRQFY(源自αs1-酪蛋白),其ACE抑制活性的IC50为(7.9±1.7)μmol/L,酶抑制动力学为混合抑制模式。分子对接结果表明:LFRQFY能与ACE的氨基酸残基Ala354(活性口袋S1)、His353(活性口袋S2)形成氢键,具有显著的体外降血压活性。     

马氏珍珠贝来源DPP-IV抑制活性肽的虚拟筛选及其作用机制

为了快速发现马氏珍珠贝来源二肽基肽酶IV（dipeptidyl peptidase IV,DPP-IV）抑制活性肽,本研究利用数据库中20个已报道的DPP-IV抑制肽组成训练集,构建了药效团模型并通过测试集分子和Fisher随机验证法对模型进行了评估。利用在线网站PeptideCutter,以珍珠贝肉蛋白为原料,进行虚拟酶解。使用最优药效团模型（Hypo1）对虚拟酶解获得的192个低分子肽（氨基酸数小于或等于5）进行初步筛选,接着以分子对接的方法进一步筛选,并且对潜在的DPP-IV抑制活性肽进行固相合成,体外验证其活性并分析其作用机制。结果表明,药效团结合分子对接技术筛选了4个理论上可能具有高活性的DPP-IV抑制肽,即LPIY、VQDR、PIY和APSL。其中,VQDR、PIY没有表现出抑制活性,而LPIY和APSL具有较高的DPP-IV抑制活性,其IC₅₀值分别为521.19 和258.67 μmol/L。与DPP-IV相互作用的机理表明,肽LPIY和APSL与DPP-IV活性口袋中的氨基酸残基形成了多个氢键,且N-端第二个位置的脯氨酸（P）也均与活性口袋中的残基形成了Pi-Alkyl作用,因此促进了LPIY和APSL的DPP-IV抑制作用。本研究为高效筛选珍珠贝来源的DPP-IV抑制肽提供了理论方法。     

谷朊粉酶解物的制备及其ACE抑制肽的分离鉴定

以谷朊粉为原料,以血管紧张素转换酶（ACE）抑制率为指标,比较4种蛋白酶的酶解效果。采用超滤、葡聚糖凝胶色谱、反相高效液相色谱（RP-HPLC）的方法分离纯化ACE抑制肽并用电喷雾飞行时间质谱联用(ESI-TOF-MS)鉴定其结构。结果表明：碱性蛋白酶酶解3 h的谷朊粉酶解物具有较高的ACE抑制活性;超滤后,分子质量Mr<1 ku的组分具有较高的ACE抑制率;分离纯化后得到小肽的ACE抑制率高达（81.03±1.20）%;由ESI-TOF-MS质谱图得出该小肽的m/z为630.89,氨基酸序列为Trp-Phe-Gln-Pro（WFQP）。     

珍珠贝水解肽的制备、氨基酸组成及抗炎活性

目的:高值化利用马氏珠母贝肉生物活性成分及马氏珠母贝肉抗炎活性肽。方法:以马氏珠母贝肉为原料,以水解度(DH)为指标,通过单因素试验和响应面试验优化珍珠贝水解肽工艺制备,并对珍珠贝水解肽的氨基酸组成和抗炎活性进行评价分析。结果:中性蛋白酶为最适酶,酶解最优工艺条件为料液比1∶1 (g/mL),酶解温度46.3℃,酶解时间1.4 h,酶底比0.3%,此时水解度为22.88%,与理论值无显著差异,回归模型可靠。酶解物中必需氨基酸含量达19.84%,疏水性氨基酸含量占比21.19%,带正电荷氨基酸含量为10.46%。在LPS诱导的小鼠巨噬细胞RAW264.7抗炎模型中,珍珠贝水解肽在0～4.0 mg/mL的质量浓度范围内无细胞毒性且有利于巨噬细胞增殖。质量浓度为2.0 mg/mL时,珍珠贝水解肽可有效抑制NO的产生,以及细胞炎症因子TNF-α、IL-6和IL-1β的生成,NO抑制率达到70.00%,TNF-α、IL-6和IL-1β抑制率分别达到83.01%,85.04%,83.11%。结论:珍珠贝水解肽的氨基酸种类齐全,其能有效抑制RAW264.7巨噬细胞NO及细胞炎症因子TNF-α、IL-...     

马氏珍珠贝软体酶法制备降糖肽的工艺优化及肽段分析

目的:以二肽基肽酶-IV（dipeptidyl peptidase，DPP-IV）抑制率和葡萄糖消耗量为指标优化马氏珍珠贝软体的酶解工艺，并对酶法制备的降糖肽进行分析。方法:以人肝癌细胞（HepG-2）胰岛素抵抗模型的葡萄糖消耗量、体外二肽基肽酶-IV（dipeptidyl peptidase，DPP-IV）抑制率为评价指标，比较筛选了酸性蛋白酶、碱性蛋白酶、中性蛋白酶、复合蛋白酶、胰蛋白酶、风味蛋白酶、木瓜蛋白酶对马氏珍珠贝软体的酶解效果，通过单因素及正交试验分析酶解温度、料液比、加酶量、酶解时间等因素对酶解物降糖活性的影响，确定最佳酶解工艺，以液相串联质谱（Nano LC-MS/MS）分析酶解物中肽类物质组成。结果:酸性蛋白酶酶解的产物葡萄糖消耗量和DPP-IV抑制率优于其他种类蛋白酶，马氏珍珠贝软体制备降糖肽的最佳酶解条件为:45 ℃、3 h、料液比1:3.5（w:w）、加酶量1000 U/g，在此条件下的葡萄糖消耗量为37.53%、DPP-IV抑制率为74.21%。最佳工艺制备的马氏珍珠贝软体酶解物中93.88%的肽段分子量低于2000 Da，22.63%的肽段为疏水性肽段，74.92%的肽段N端至少有含有一个疏水性氨基酸。结论:本研究酶法制备的马氏珍珠贝软体降糖肽可通过抑制DPP-IV的活性及减少胰岛素抵抗发挥降糖作用，对功能食品的研发具有一定的指导意义。     

三斑海马蛋白ACE抑制肽的制备及其二级结构的研究

以三斑海马为原料,经碱性蛋白酶酶解,获得富含血管紧张素转化酶(angiotensin I-converting enzyme,ACE)抑制肽的酶解液。酶解液经透析、Sephadex G-25凝胶过滤色谱和反相高效液相色谱得到进一步分离纯化。结果表明,透析产物的IC50值为(0.44±0.26)mg/mL,相比酶解液(0.81±0.12)mg/mL,其ACE抑制活性更强。透析产物经Sephadex G-25凝胶柱分离纯化后,得到3种组分,其中组分F2的ACE抑制活性最强,IC50值为(0.11±0.08)mg/mL。F2经反相高效液相色谱进一步分离后,得到6个具有ACE抑制活性的组分峰,其中组分F2-4的ACE抑制活性最强,IC50值为(0.005 7±0.000 9)mg/mL。经过3步分离纯化后,成功从三斑海马蛋白中分离得到一种活性较强ACE抑制肽:ProAla-Gly-Pro-Arg-Gly-Pro-Ala(PAGPRGPA),多肽分子量为721.39 Da。圆二色谱分析多肽二级结构表明其主要含无规则卷曲。因此,从三斑海马蛋白中分离得到的多肽可能成为营养保健品和抗高血压药品及相关疾病的一种有益成分,且对海马蛋白资源的开发利用具有重要意义。     

Purification and identification of angiotensin converting enzyme inhibitory peptides from beef hydrolysates

Sarcoplasmic protein extracts from beef rump (biceps femoris) were hydrolyzed (for 0, 4, 8, 12, and 24 h) with three enzymes or their paired combinations. Ultrafiltration, gel-filtration, and RP-HPLC were used to separate angiotensin converting enzyme (ACE) inhibitory peptides from the hydrolysates. The highest ACE inhibitory activity of enzyme hydrolysates resulted from 4 h incubation with enzymes or their paired combinations. The activities of gel filtrated fractions from these hydrolysates were assayed in vitro, demonstrating that the 3rd peak of enzyme thermolysin + proteinase A hydrolysate had the highest ACE inhibition activity (52.8%). The 3rd peak of this hydrolysate was separated by RP-HPLC into five peaks, of which peak 3 showed 30.1% ACE inhibition activity. Its peptide sequence was determined to be Val-Leu-Ala-Gln-Tyr-Lys. The results suggested that this peptide may be a potent ACE inhibitor which might perhaps be used to develop beef with a bioactive peptide to lower blood pressure.     

体外模拟消化对大米谷蛋白结构及水解产物生物活性的影响

通过体外模拟消化,研究不同消化时间下谷蛋白结构与抗氧化和血管紧张素转换酶（angiotensin-converting enzyme,ACE）抑制活性的关系。利用内源荧光光谱和傅里叶变换红光谱测定谷蛋白水解过程结构变化。通过测定水解产物抗氧化能力和ACE抑制率表征酶解产物的活性,利用四极杆串联飞行时间质谱鉴定具有抗氧化和ACE抑制活性的组分。结果表明,谷蛋白水解度在2 h内快速增加,随后趋于平缓。水解导致谷蛋白λmax红移且荧光强度增强,α-螺旋含量显著增加、β-折叠相对含量显著降低（P＜0.05）。α-螺旋结构含量的增加降低了水解物的抗氧化能力,谷蛋白β-折叠结构含量的减少能增强水解物的ACE抑制能力。水解0.5 h抗氧化能力最强,1,1-二苯基-2-三硝基苯肼自由基清除率的半抑制浓度（half maximal inhibitory concentration,IC50）为（1.113±0.015）mg/mL,·OH清除率IC50为（0.518±0.053）mg/mL、Fe2＋螯合能力IC50为（0.678±0.019）mg/mL。ACE抑制率先增加后降低,在2 h达到最高,IC50为（0.693±0.011）mg/mL。水解度的增加降低了水解物抗氧化能力,但增强了ACE抑制能力。水解物在0.5～2 h抗氧化能力和ACE抑制能力呈现负相关关系,随后抗氧化能力和ACE抑制能力均下降。水解物抗氧化肽和ACE抑制肽分子质量均小于2 kDa,筛选出以VEGGFLFIV为代表抗氧化活性多肽,且ACE抑制肽大部分N-端是疏水性氨基酸或者碱性氨基酸。因此,通过控制谷蛋白体外消化水解度,可制备最优的大米谷蛋白抗氧化或降血压相关功能性产品。     

Studies on purification and the molecular mechanism of a novel ACE inhibitory peptide from whey protein hydrolysate

This study sought to purify and identify a novel angiotensin I-converting enzyme (ACE) inhibitory peptide from whey protein hydrolysed by trypsin. The peptide’s amino acid sequence, as well as the molecular mechanism of the interactions between the peptide and the ACE, were also studied. Using ultrafiltration, the hydrolysate was separated into three fractions. The fraction with molecular weight of <6 kDa had the greatest ACE inhibitory activity and was further separated by size exclusion chromatography on Sephadex G-25 and G-10 columns. Reverse-phase high performance liquid chromatography (RP-HPLC) was used to separate the most active fraction. The amino acid sequence of the peptide with the greatest ACE inhibitory characteristics was confirmed as Leu–Leu (LL). The molecular mechanisms, position, type, and energy of the LL/ACE interaction were investigated by using flexible molecule docking technology.     

Purification and identification of ACE inhibitory peptides from Haruan (Channa striatus) myofibrillar protein hydrolysate using HPLC–ESI-TOF MS/MS

Haruan myofibrillar protein was hydrolysed with proteinase K and thermolysin to isolate Angiotensin converting enzyme (ACE) inhibitory peptides. The thermolysin hydrolysate of myofibrillar protein with the highest ACE inhibition activity (IC₅₀ = 0.033 mg/ml) was fractionated by ultrafiltration and size exclusion chromatography to three fractions. Fraction F2 with higher ACE inhibitory activity was separated into five fractions (A–E) using reversed-phased high performance liquid chromatography (RP-HPLC). Fraction C showed 81% inhibition activity and was subjected to HPLC coupled to electrospray ionisation-time-of-flight mass spectrometry (ESI-TOF MS/MS). Two peptide sequences for the most abundant fragments were identified as VPAAPPK (IC₅₀ = 0.45 μM) at 791.155 m/z and NGTWFEPP (IC₅₀ = 0.63 μM) at 1085.841 m/z. The presence of two proline residues at the C-terminal sequence is responsible for the high ACE inhibitory activity of these peptides. The results suggest that Haruan meat protein hydrolysate is a potent ACE inhibitor and may be used to decrease blood pressure.     

利用对虾消化腺丝氨酸蛋白酶制备鲍鱼外套膜ACE抑制肽

利用鲍鱼加工副产物外套膜制备具有抑制血管紧张素转移酶（angiotensin converting enzyme,ACE）活性的生物活性肽,为鲍鱼加工副产物的高值化利用提供新思路。采用从凡纳滨对虾消化腺中制备的丝氨酸蛋白酶,酶解皱纹盘鲍外套膜蛋白,以酶解物ACE抑制活性为评价指标优化条件。酶解液通过3 kDa超滤膜后,活性组分经过Superdex peptide 10/300 GL凝胶过滤柱和反相高效液相色谱（reversed-phase high performance liquid chromatography,RP-HPLC）分离纯化,利用液相色谱-质谱（liquid chromatography tandem mass spectrometry,LC-MS/MS）鉴定纯化肽的氨基酸序列。结果显示,酶解液的ACE抑制率为13.42%,经3 kDa超滤膜初步分级后,相同浓度下,小于3 kDa的组分ACE抑制率为53.25%。经凝胶过滤柱和反相高效液相色谱柱进一步分离后,从ACE抑制活性最高的峰中鉴定得到5个肽段,序列为LGDSFYYGK、LVNEVTEFAK、VDEVGGEALGR、MFLSFPTTK、VATVSLPR,说明活性峰是多肽混合物。本研究利用鲍鱼外套膜制备ACE抑制肽,可以为鲍鱼及对虾加工副产物的高值化利用提供理论参考。     

Purification and identification of an ACE inhibitory peptide from the peptic hydrolysate of Acetes chinensis and its antihypertensive effects in spontaneously hypertensive rats

Acetes chinensis is a marine shrimp found in the coastal waters of China. The shrimp was hydrolysed by pepsin to prepare hydrolysates with angiotensin I‐converting enzyme (ACE) inhibitory activity. The hydrolysate with the highest ACE inhibitory activity resulted from a 3–5 h incubation at 45 °C and pH 2.5 with pepsin. Gel filtration and RP‐HPLC were used to separate ACE inhibitory peptides from the hydrolysate. The gel filtration fraction of the hydrolysate with a molecular weight range from 1320 Da to 311 Da exerted the highest ACE inhibition activity. This fraction was separated by RP‐HPLC into fifteen fractions, of which fraction F9 showed 92.7% of the ACE inhibition activity. Its peptide sequence was determined to be Leu–His–Pro. It showed a potent antihypertensive activity in spontaneously hypertensive rats. The results suggested that this peptide may be a potent ACE inhibitor which might be developed into a healthy food to lower blood pressure.     

Optimization of peptic hydrolysis parameters for the production of angiotensin I-converting enzyme inhibitory hydrolysate from Acetes chinensis through Plackett-Burman and response surface methodological approaches

BACKGROUND: Angiotensin I‐converting enzyme (ACE) plays an important physiological role in regulating blood pressure. The elevation of blood pressure could be suppressed by inhibiting ACE. ACE inhibitory peptides derived from food proteins could exert antihypertensive effects without side effects. Acetes chinensis is a marine shrimp suitable for the production of ACE inhibitory peptides. The principal objective of this study was to screen for the significant variables, and further to optimize the levels of the selected variables, for the enzymatic production of ACE inhibitory peptides from Acetes chinensis. RESULTS: Plackett–Burman design and response surface methodology were employed to optimize the peptic hydrolysis parameters of Acetes chinensis to obtain a hydrolysate with potent ACE inhibitory activity. The peptic hydrolysis variables were subject to a Plackett–Burman design for screening the main factors. The selected significant parameters such as pH, hydrolysis temperature and enzyme/substrate (E/S) ratio were further optimized using a central composite design. The optimized conditions were: pH 2.5, hydrolysis temperature 45 °C, E/S ratio 17 800 U kg^?1 shrimp and substrate concentration 200 g L^?1. The results showed that 3–5 h hydrolysis could result in a hydrolysate with ACE inhibition IC₅₀ of 1.17 mg mL^?1 and a high DH of 25–27%. CONCLUSION: Plackett–Burman design and RSM performed well in the optimization of peptic hydrolysis parameters of Acetes chinensis to produce hydrolysate with ACE inhibitory activity. A hydrolysate with potent ACE inhibitory activity and high degree of hydrolysis was obtained, so that the yield of ACE inhibitory peptides in it was high. Copyright © 2011 Society of Chemical Industry     

南瓜籽蛋白源血管紧张素转化酶抑制肽的制备及其降血压活性

食源性降血压肽在调节机体血压过程中发挥着一定的积极作用。本实验采用碱性蛋白酶水解南瓜籽蛋白,水解物经膜分离获得血管紧张素转化酶（angiotensin converting enzyme,ACE）抑制肽,通过质谱鉴定其结构,并采用抑制动力学和分子对接方法研究ACE抑制肽的活性机制;此外,通过ACE抑制活性实验、自发性高血压大鼠（spontaneously hypertensive rats,SHRs）模型等评价南瓜籽蛋白水解物、膜分离组分以及南瓜籽肽的降血压活性。结果表明,低于1 kDa南瓜籽蛋白水解物组分ACE抑制活性较好,1 mg/mL下ACE抑制率为46.22%,100 mg/kg mb 剂量下灌胃SHRs 6 h后收缩压可以降低21.42 mm Hg;鉴定出9 个ACE抑制肽（LLV、LVF、LTPL、SVLF、LLPQ、MLPL、LLPGF、VLLPE和RFPLL）,其中RFPLL、LLPGF、MLPL和LVF具有较好的ACE抑制活性,半抑制浓度均低于1 mmol/L;RFPLL和LVF具有较好的降血压活性,30 mg/kg mb剂量下灌胃6 h后SHRs的收缩压降低量分别为37.0 mm Hg和22.2 mm Hg,SHRs的舒张压降低量分别为17.0 mm Hg和11.2 mm Hg;RFPLL、LLPGF、MLPL和LVF可以很好地对接ACE的活性中心,RFPLL是ACE混合型抑制剂,MLPL对ACE的抑制模式可能是竞争型抑制,LLPGF、LVF可能是ACE的非竞争型抑制剂。综上,低于1 kDa南瓜籽蛋白水解物是一种良好的降血压功能食品原料,其中RFPLL和LVF可用于降血压功能食品或者药品的开发原料。